Science Explorer Back to mapMap
Discussion
Researcher · Novartis (Switzerland) · Switzerland

David A. Ruddy

David A. Ruddy publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Cancer Genomics and Diagnostics, Melanoma and MAPK Pathways and PI3K/AKT/mTOR signaling in cancer.

ORCID 0000-0001-8244-5609 OpenAlex
World rank
#60,388
of 7,710,434 ranked researchers
Rank in Switzerland
#1,272
of 80,918
Works
369
Citations
13k
Citations per work
36.1
h-index
34
i10-index 48Top 11% in Molecular Biology
David A. Ruddy

What does David A. Ruddy research?

David A. Ruddy's work is mostly in Biochemistry, Genetics and Molecular Biology (45%), Medicine (20%), Immunology and Microbiology (6%).

Life Sciences: 185 works · 50.2% of their workBiochemistry, Genetics and Molecular Biology: 165 works · 44.6% of their workMolecular Biology: 142 works · 38.6% of their workCancer Research: 22 works · 6.0% of their workImmunology and Microbiology: 21 works · 5.6% of their workImmunology: 21 works · 5.6% of their workEverything else: 96 works · 26.1% of their workHealth Sciences: 76 works · 20.5% of their workMedicine: 76 works · 20.5% of their workOncology: 52 works · 14.1% of their workPulmonary and Respiratory Medicine: 24 works · 6.4% of their workPhysical Sciences: 12 works · 3.2% of their workComputer Science: 12 works · 3.2% of their workComputational Theory and Mathematics: 12 works · 3.2% of their workTHEIR WORKDavid A. Ruddy369works
Life Sciences50%Physical Sciences3%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology16544.6%
    2. Immunology and Microbiology215.6%
  2. Everything else9626.1%
    1. Medicine7620.5%
    1. Computer Science123.2%
  1. 1Molecular Biology39% of their works
  2. 2Oncology14% of their works
  3. 3Pulmonary and Respiratory Medicine6% of their works
  4. 4Cancer Research6% of their works
  5. 5Immunology6% of their works
  6. 6Computational Theory and Mathematics3% of their works

Research topics

Which keywords describe David A. Ruddy's research?

The keywords of their largest research topics: Targeted Therapy, Cancer Progression, BRAF gene, Cancer Genomics, MAP Kinase, Mutational Signatures, ALK Inhibitors and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Targeted Therapy212 topics
  2. Cancer Progression162 topics
  3. BRAF gene121 topic
  4. Cancer Genomics121 topic
  5. MAP Kinase121 topic
  6. Mutational Signatures121 topic
  7. ALK Inhibitors91 topic
  8. EGFR Mutations91 topic
  9. Signaling91 topic
  10. mTOR91 topic
  11. Pim Oncogenes81 topic
  12. RNA methylation81 topic
  13. Tumorigenesis81 topic
  14. m6A-seq81 topic
  15. BET Bromodomains71 topic
  16. Genome Engineering71 topic
  17. PROTACs71 topic
  18. RNA-Guided71 topic

Where does David A. Ruddy work?

David A. Ruddy's main affiliation in the publication record is Novartis (Switzerland), Switzerland.

How many publications and citations does David A. Ruddy have?

OpenAlex counts 369 works and 13,309 citations for David A. Ruddy, an h-index of 34, ranking #60,388 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David A. Ruddy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.